These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 10651939)
41. Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. Giannini E; Brouchon L; Boulay F J Biol Chem; 1995 Aug; 270(32):19166-72. PubMed ID: 7642584 [TBL] [Abstract][Full Text] [Related]
42. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363 [TBL] [Abstract][Full Text] [Related]
43. Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody. Soruri A; Kim S; Kiafard Z; Zwirner J Immunol Lett; 2003 Jul; 88(1):47-52. PubMed ID: 12853161 [TBL] [Abstract][Full Text] [Related]
44. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus]. Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327 [TBL] [Abstract][Full Text] [Related]
45. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. Floreani AA; Heires AJ; Welniak LA; Miller-Lindholm A; Clark-Pierce L; Rennard SI; Morgan EL; Sanderson SD J Immunol; 1998 May; 160(10):5073-81. PubMed ID: 9590258 [TBL] [Abstract][Full Text] [Related]
46. Human T cells express the C5a receptor and are chemoattracted to C5a. Nataf S; Davoust N; Ames RS; Barnum SR J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923 [TBL] [Abstract][Full Text] [Related]
47. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry. Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041 [TBL] [Abstract][Full Text] [Related]
48. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308 [TBL] [Abstract][Full Text] [Related]
49. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Lee H; Whitfeld PL; Mackay CR Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853 [TBL] [Abstract][Full Text] [Related]
50. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis. Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419 [TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation. Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894 [TBL] [Abstract][Full Text] [Related]
52. Upregulation of fibronectin but not of entactin, collagen IV and smooth muscle actin by anaphylatoxin C5a in rat hepatic stellate cells. Schlaf G; Schmitz M; Heine I; Demberg T; Schieferdecker HL; Götze O Histol Histopathol; 2004 Oct; 19(4):1165-74. PubMed ID: 15375759 [TBL] [Abstract][Full Text] [Related]
53. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. Daveau M; Benard M; Scotte M; Schouft MT; Hiron M; Francois A; Salier JP; Fontaine M J Immunol; 2004 Sep; 173(5):3418-24. PubMed ID: 15322206 [TBL] [Abstract][Full Text] [Related]
54. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity. Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476 [TBL] [Abstract][Full Text] [Related]
55. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity. Vogen SM; Finch AM; Wadi SK; Thatcher J; Monk PN; Taylor SM; Sanderson SD J Pept Res; 1999 Jan; 53(1):8-17. PubMed ID: 10195437 [TBL] [Abstract][Full Text] [Related]
56. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Reiman R; Gerard C; Campbell IL; Barnum SR Eur J Immunol; 2002 Apr; 32(4):1157-63. PubMed ID: 11932923 [TBL] [Abstract][Full Text] [Related]
57. 1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA. Rubin J; Biskobing D; Titus L; Thornton DL; Catherwood BD; Nanes MS Am J Med Sci; 1996 Feb; 311(2):73-9. PubMed ID: 8615377 [TBL] [Abstract][Full Text] [Related]
58. Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction. van Werkhoven MB; Damman J; van Dijk MCRF; Daha MR; de Jong IJ; Leliveld A; Krikke C; Leuvenink HG; van Goor H; van Son WJ; Olinga P; Hillebrands JL; Seelen MAJ Am J Transplant; 2013 Apr; 13(4):875-882. PubMed ID: 23398742 [TBL] [Abstract][Full Text] [Related]
59. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. Tardif M; Mery L; Brouchon L; Boulay F J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487 [TBL] [Abstract][Full Text] [Related]
60. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Morelli A; Larregina A; Chuluyán I; Kolkowski E; Fainboim L Immunology; 1996 Sep; 89(1):126-34. PubMed ID: 8911150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]